According to the research report titled ‘GLOBAL BOTULINUM TOXIN MARKET 2021-2028’, available with MarketStudyReport, global botulinum toxin market is on track to register a y-o-y growth rate of 5.55% over the forecast period 2021-2028.

Increasing demand for aesthetic procedures, coupled with new applications of the product in therapeutics are the primary factors driving global botulinum toxin market growth. Additionally, a gradual rise in geriatric population, and surge in medical tourism will present new growth opportunities to businesses operating in this domain.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/3855547/

Moreover, a noticeable rise in the number of males opting for cosmetic procedures, and increasing focus on development of healthcare infrastructure are also positively swaying the industry outlook.

On the downside, side-effects associated with the use of botulinum toxin, lack of proper reimbursement policies in various countries, and difficulties in interchangeability between these products are restricting the development of the studied market.

Based on product type, global botulinum toxin market is bifurcated into type A and type B. By application scope, the industry classification comprises cosmetic (lateral canthal lines (crow's feet) glabellar lines, forehead lines, other cosmetic applications), and non-cosmetic (dystonia, ophthalmologic disorders, chronic migraine, others). Moving on to end user scope, the business sphere is arrayed into hospitals, clinics, and others.

On the regional front, the size and scope of the industry is measured across regions including Latin America, Middle East & Africa, Asia-Pacific, North America, and Europe. Of these, Asia-Pacific market is expected to amass notable gains over 2021-2028, owing to rise in aging population and the high disposable income among people, which is creating a higher demand for products with anti-aging properties. Furthermore, increasing social awareness about availability of these products commercially is likely to stimulate regional industry growth in the upcoming years.

Considering the competitive outlook, companies like Medytox Inc., Merz Pharma GmbH & Co. KGaA, Ipsen Pharma, Hugel Inc., Galderma (EQT AB), Evolus Inc., Revance, USWM LLC, and AbbVie Inc. are predominantly affecting worldwide botulinum toxin industry dynamics.